$85.53 0.00%
AMED Stock Price vs. AI Score
Data gathered: December 12

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Amedisys (AMED)

Analysis generated September 26, 2024. Powered by Chat GPT.

Amedisys, Inc. is a home health care company based in Baton Rouge, Louisiana. The firm primarily operates in three segments: Home Health Care, Hospice Care, and Personal Care. Amedisys delivers a broad range of health care services to enable its patients to recover comfortably at home, thus reducing hospital readmission rates and lowering overall costs. With a robust network of compassionate healthcare professionals, Amedisys has established itself as a pivotal player in the home health care industry, committed to improving the quality of life for its patients.

Read full AI stock Analysis

Stock Alerts - Amedisys (AMED)

company logo Amedisys | December 3
Price is down by -5.2% in the last 24h.
company logo Amedisys | November 11
Price is down by -5.9% in the last 24h.
company logo Amedisys | November 1
Job postings are down by 17.2% in the last couple of days.
company logo Amedisys | October 23
Job postings are down by 16.4% in the last couple of days.

About Amedisys

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care.


Amedisys
Price $85.53
Target Price Sign up
Volume 564,800
Market Cap $2.8B
Year Range $84.78 - $98.45
Dividend Yield 0%
PE Ratio 33.94
Analyst Rating 0% buy
Industry Medical Care Facilities

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24588M692M-104M17M35M0.000
Q2 '24591M668M-77M32M61M1.320
Q1 '24571M668M-96M14M39M1.030
Q4 '23571M673M-681M19M36M0.940
Q3 '23556M643M-651M26M51M0.980

Insider Transactions View All

North Michael Paul filed to sell 4,164 shares at $86.4.
March 8 '23
Bohnert Denise M. filed to sell 11,850 shares at $115.
June 27 '22
Kemmerly David L filed to sell 18,816 shares at $175.2.
April 4 '22
Kemmerly David L filed to sell 16,336 shares at $177.9.
April 4 '22
Kemmerly David L filed to sell 16,779 shares at $177.2.
April 4 '22

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
Apr 7, 23 Sell $1K - $15K
Rohit Khanna
Democrat
Apr 7, 23 Sell $1K - $15K
Rohit Khanna
Democrat
Mar 8, 23 Buy $1K - $15K

What is the Market Cap of Amedisys?

The Market Cap of Amedisys is $2.8B.

What is Amedisys' PE Ratio?

As of today, Amedisys' PE (Price to Earnings) ratio is 33.94.

What is the current stock price of Amedisys?

Currently, the price of one share of Amedisys stock is $85.53.

How can I analyze the AMED stock price chart for investment decisions?

The AMED stock price chart above provides a comprehensive visual representation of Amedisys' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amedisys shares. Our platform offers an up-to-date AMED stock price chart, along with technical data analysis and alternative data insights.

Does AMED offer dividends to its shareholders?

As of our latest update, Amedisys (AMED) does not offer dividends to its shareholders. Investors interested in Amedisys should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Amedisys?

Some of the similar stocks of Amedisys are Encompass Health, Brookdale Senior Living, DaVita, Tenet Healthcare, and Encompass Health.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.